D68.62
Lupus anticoagulant syndrome
Risk-adjusting (HCC)Billable code
HCC risk adjustment mapping
CMS-HCC ESRD V24
HCC48
Coagulation Defects and Other Specified Hematological Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
This code · D68.62
Inherited from D68.6Other thrombophilia
Inherited from D68Other coagulation defects
Inherited from chapter 3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Excludes 2
autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Official Guidelines for D68.62
FY 2026 ›Find D68.62 in the alphabetic index
8 index paths lead to this code
- Inhibitor, systemic lupus erythematosus
- Lupus › anticoagulant
- Presence › systemic lupus erythematosus [SLE] inhibitor
- Syndrome › Lupus anticoagulant
- System, systemic › lupus erythematosus › inhibitor present
- Lupus › anticoagulant › with › hypercoagulable state
- Lupus › erythematosus › systemic › inhibitor
- Lupus › erythematosus › systemic › inhibitor › with › hypercoagulable state